I
Ingrid J. Hickman
Researcher at Princess Alexandra Hospital
Publications - 128
Citations - 3937
Ingrid J. Hickman is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Weight loss & Insulin resistance. The author has an hindex of 25, co-authored 112 publications receiving 3498 citations. Previous affiliations of Ingrid J. Hickman include Translational Research Institute & Queensland University of Technology.
Papers
More filters
Journal ArticleDOI
Adiponectin--a key adipokine in the metabolic syndrome.
Jonathan P. Whitehead,Ayanthi A. Richards,Ingrid J. Hickman,Graeme A. Macdonald,Johannes B. Prins +4 more
TL;DR: Given the low levels of adiponectin in subjects with the metabolic syndrome, and the beneficial effect of the adipokine in animal studies, there is exciting potential for adiponECTin replacement therapy in insulin resistance and related disorders.
Journal ArticleDOI
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life
Ingrid J. Hickman,J. R. Jonsson,Johannes B. Prins,Susan Ash,D. M. Purdie,Andrew D. Clouston,Elizabeth E. Powell +6 more
TL;DR: It is demonstrated that maintenance of weight loss and exercise in overweight patients with liver disease results in a sustained improvement in liver enzymes, serum insulin levels, and quality of life.
Journal ArticleDOI
Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C
Ingrid J. Hickman,Andrew D. Clouston,Graeme A. Macdonald,David M. Purdie,Johannes B. Prins,Susan Ash,J. R. Jonsson,Elizabeth E. Powell +7 more
TL;DR: Weight reduction in patients with chronic hepatitis C may be associated with a reduction in steatosis and abnormal liver enzymes and an improvement in fibrosis, despite the persistence of the virus.
Journal ArticleDOI
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique S. Chachay,Graeme A. Macdonald,Jennifer H. Martin,Jonathan P. Whitehead,Trisha O'Moore-Sullivan,Paul Lee,Michael E. Franklin,Kerenaftali Klein,Paul J. Taylor,Maree Ferguson,Jeff S. Coombes,Gethin P. Thomas,Gary Cowin,Carl M. J. Kirkpatrick,Johannes B. Prins,Ingrid J. Hickman +15 more
TL;DR: Eight weeks administration of resveratrol did not significantly improve any features of NAFLD, compared with placebo, but it increased hepatic stress, based on observed increases in levels of liver enzymes.
Journal ArticleDOI
In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy
Ingrid J. Hickman,Elizabeth E. Powell,Johannes B. Prins,Andrew D. Clouston,Susan Ash,David M. Purdie,Julie R. Jonsson +6 more
TL;DR: Increasing circulating insulin levels may be a factor responsible for the association between BMI and fibrosis in patients with HCV, irrespective of viral genotype.